Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trialJonathan Gelfond, Michael A. Liss, Osamah Al-Bayati et al.|Urologic Oncology Seminars and Original Investigations|2018Cited by 20